CMA pauses pharma probes to focus on covid-19

The UK’s Competition and Markets Authority has “paused” two probes into suspected collusion in the pharmaceutical sector as it reallocates resources to deal with the coronavirus pandemic.


Get unlimited access to all Global Competition Review content